Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as:

• Obeticholic acid
• Cenicriviroc
• Resmetirom
• Aramchol

Download the slides from this podcast at:
https://bit.ly/3eJYKvW

See more NASH topics at: 
https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.